Novartis AG Goodwill Expected Deductible For Tax Purposes
Novartis AG (NVS) had Goodwill Expected Deductible For Tax Purposes of $0 as of 2023-12-31, per its 20-F filed 2025-01-31.
Financial Statements › Notes › Intangible Assets
ifrs-full:GoodwillExpectedDeductibleForTaxPurposes · last filed 2025-01-31
- 2023-12-31: Goodwill Expected Deductible For Tax Purposes $0.00.
- 2022-12-31: Goodwill Expected Deductible For Tax Purposes $0.00.
- 2022-06-30: Goodwill Expected Deductible For Tax Purposes $0.00.
- 2021-12-31: Goodwill Expected Deductible For Tax Purposes $107.00M.
| Period end | Goodwill Expected Deductible For Tax Purposes |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2025-01-31 |
| 2022-12-31 | $0.00 20-F · filed 2024-01-31 |
| 2022-06-30 | $0.00 6-K · filed 2023-07-18 |
| 2021-12-31 | $107.00M 20-F · filed 2024-01-31 |
| 2021-06-30 | $0.00 6-K · filed 2022-07-19 |
| 2020-12-31 | $74.00M 20-F/A · filed 2023-05-15 |
| 2020-06-30 | $59.00M 6-K · filed 2021-07-21 |
| 2019-12-31 | $98.00M 20-F · filed 2022-02-02 |
| 2019-06-30 | $0.00 6-K · filed 2020-07-21 |
| 2018-12-31 | $0.00 20-F · filed 2021-01-26 |
| 2017-12-31 | $0.00 20-F · filed 2020-01-29 |
| 2016-12-31 | $18.00M 20-F · filed 2019-01-30 |
| 2015-12-31 | $2.40B 6-K · filed 2018-01-24 |